Immunovaccine
Now IMV, a company developing vaccines for cancer therapy, infectious diseases and animal health
1
Funding Rounds
$4.2m
Money raised
Overview
Now IMV, a company developing vaccines for cancer therapy, infectious diseases and animal health
-
Website:
- Social accounts:
Funding series
Funding Series Analysis
The company Immunovaccine has raised a total of $4.2m in funding over 1 rounds.
Key Insights:
- Immunovaccine funding round, November 2013: $4.2m
Immunovaccine funding round, November 2013
$4.2m